Adjuvant nitrosoureas: will they ever go away?

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.

Nature communications·2024

Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.

JAMA oncology·2022

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma.

Neuro-oncology advances·2022

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).

Neuro-oncology advances·2022

Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD).

Cancer·2021

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2020

How 'Sturgeon' guides the surgeon in pediatric neuro-oncology.

Neuro-oncology·2026

CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.

Neuro-oncology·2026

Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma.

Neuro-oncology·2026

Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.

Neuro-oncology·2026

Siglec-15 and PD-1 checkpoint blockade in combination with oncolytic Zika virus infection confers protection against immune-resistant gliomas.

Neuro-oncology·2026

Phase 2 test of QBS72S for breast cancer leptomeningeal disease.

Neuro-oncology·2026

Gut-Mediated Systemic Toxicity of Micro- and Nanoplastics: Nanoscale Biointerface Properties, Microbiota-Metabolite Crosstalk, and Evidence Across Gut-Organ Axes.

Nanomaterials (Basel, Switzerland)·2026

Peroxynitrite-induced structural remodeling and aggregation of hemoglobin under nitroxidative stress.

Protein science : a publication of the Protein Society·2026

Air pollution and chronic obstructive pulmonary disease-related health outcomes: a bibliometric and visualization analysis.

Journal of thoracic disease·2026

Thiram inhibits human sperm motility and capacitation by increasing mitochondrial O2 - and reducing PTK and PAK4 activity at environmental concentrations.

Translational andrology and urology·2026

Collective trauma in the wake of historical environmental contamination.

Journal of health psychology·2026

Potentially toxic elements in multi-stressor marine environments: bioaccumulation, ecosystem impacts, and human health implications.

Environmental geochemistry and health·2026

Related Experiment Videos

Adjuvant nitrosoureas: will they ever go away?

Related Concept Videos

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.

Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma.

Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).

Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD).

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

How 'Sturgeon' guides the surgeon in pediatric neuro-oncology.

CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.

Potent anti-tumor preclinical efficacy of B7-H3 CAR-T cells in H3G34-mutant, Diffuse Hemispheric Glioma.

Stereotactic Radiosurgery Outcomes for Radiation-Induced Meningiomas After Childhood Tinea Capitis Irradiation: A Comparative Study with Sporadic Meningiomas.

Siglec-15 and PD-1 checkpoint blockade in combination with oncolytic Zika virus infection confers protection against immune-resistant gliomas.

Phase 2 test of QBS72S for breast cancer leptomeningeal disease.

Gut-Mediated Systemic Toxicity of Micro- and Nanoplastics: Nanoscale Biointerface Properties, Microbiota-Metabolite Crosstalk, and Evidence Across Gut-Organ Axes.

Peroxynitrite-induced structural remodeling and aggregation of hemoglobin under nitroxidative stress.

Air pollution and chronic obstructive pulmonary disease-related health outcomes: a bibliometric and visualization analysis.

Thiram inhibits human sperm motility and capacitation by increasing mitochondrial O2 - and reducing PTK and PAK4 activity at environmental concentrations.

Collective trauma in the wake of historical environmental contamination.

Potentially toxic elements in multi-stressor marine environments: bioaccumulation, ecosystem impacts, and human health implications.

Related Experiment Videos

Adjuvant nitrosoureas: will they ever go away?

Related Concept Videos

Related Articles